Takeda confirms acquisition of Nycomed for €9.6bn
This article was originally published in Scrip
Executive Summary
Putting an end to speculation that has been swirling around for a week, Takeda has now confirmed that it will acquire Nycomed for €9.6 billion, in a deal that excludes the private Swiss group's US dermatology business.